Holen Sie sich die Stockscreener-App
317.25
4.71%
-15.67
Handel nachbörslich:
317.25
Praxis Precision Medicines Inc Aktie (PRAX) Neueste Nachrichten
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - Yahoo Finance
Can Praxis Precision Medicines Inc. outperform in the next rallyProfit Target & Reliable Price Action Trade Plans - mfd.ru
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800 - Finviz
Is Praxis Precision Medicines Inc. exposed to currency risks2025 AllTime Highs & Real-Time Chart Pattern Alerts - mfd.ru
Soleus Adds a Significant Number of Celcuity Shares - The Motley Fool
Praxis Precision Medicines stock hits 52-week high at 327.0 USD - Investing.com Nigeria
Is Praxis Precision Medicines Inc.’s ROIC above industry average2025 Biggest Moves & Fast Moving Stock Trade Plans - mfd.ru
PRAX: Two NDAs set for mid-February aim to address major CNS markets with strong launch plans - TradingView
Arizona State Retirement System Purchases Shares of 5,417 Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Will Praxis Precision Medicines Inc. stock attract more institutional investors2025 Price Targets & Real-Time Stock Price Movement Reports - mfd.ru
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) | PRAX Stock News - GuruFocus
Guggenheim raises Praxis Precision Medicines stock price target on essential tremor opportunity By Investing.com - Investing.com South Africa
Guggenheim raises Praxis Precision Medicines stock price target on essential tremor opportunity - Investing.com Canada
Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year HighHere's Why - MarketBeat
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences - Investing News Network
Praxis Precision Medicines to Report Fourth Quarter and - GlobeNewswire
Praxis Precision Medicines stock hits 52-week high at 327.0 USD By Investing.com - Investing.com South Africa
A Look At Praxis Precision Medicines (PRAX) Valuation As Analysts Reaffirm Bullish CNS Pipeline Views - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Avoiding Lag: Real-Time Signals in (PRAX) Movement - Stock Traders Daily
Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 6-FEB-2026. - marketscreener.com
Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 6-FEB-2026. - marketscreener.com
Is Praxis Precision Medicines (PRAX) Now Pricing In Recent Pipeline Progress And Volatile Share Gains - Sahm
Praxis Precision Medicines (PRAX) Price Target Increased by 26.75% to 597.99 - Nasdaq
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Praxis Precision Medicines, Inc. announces inducement grants under Nasdaq Listing Rule - marketscreener.com
Needham Raises Price Target for Praxis Precision Medicine (PRAX) - GuruFocus
Needham & Company LLC Boosts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $510.00 - MarketBeat
Why Praxis Precision Medicines (PRAX) Is Up 5.1% After Dual NDA Plans And Data Platform Expansion - Sahm
Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Praxis Precision Medicines (PRAX) - The Globe and Mail
Wells Fargo Initiates Coverage of Praxis Precision Medicines (PRAX) with Equal-Weight Recommendation - Nasdaq
SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders - 01net
Wells Fargo Initiates Coverage on PRAX with Equal-Weight Rating - GuruFocus
Wells Fargo Initiates Coverage on Praxis Precision Medicines With Equal Weight Rating, $282 Price Target - marketscreener.com
Praxis Precision Medicines (NASDAQ:PRAX) Now Covered by Analysts at Wells Fargo & Company - MarketBeat
A Look At Praxis Precision Medicines (PRAX) Valuation After Breakthrough NDA Plans And Rising Investor Interest - Sahm
Aug Chart Watch: Is Praxis Precision Medicines Inc stock a smart retirement pickAnalyst Upgrade & Safe Capital Growth Tips - baoquankhu1.vn
3,846 Shares in Praxis Precision Medicines, Inc. $PRAX Acquired by Coastal Bridge Advisors LLC - MarketBeat
Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a 63% Upside in the Biotech Sector - DirectorsTalk Interviews
PRAX: HC Wainwright & Co. Raises Price Target and Maintains Buy Rating | PRAX Stock News - GuruFocus
H.C. Wainwright raises Praxis Precision Medicines stock price target to $1,245 - Investing.com Nigeria
Y Intercept Hong Kong Ltd Makes New $1.71 Million Investment in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines plans two NDA submissions by mid-February - Investing.com Nigeria
Phoenix Financial Ltd. Makes New Investment in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Piper Sandler raises Praxis Precision Medicines stock price target to $1,200 - Investing.com Canada
Is Praxis Precision Medicines Inc part of any major indexTrade Analysis Report & Daily Market Momentum Tracking - baoquankhu1.vn
Piper Sandler Raises PRAX Price Target to $1,200, Maintains Overweight Rating | PRAX Stock News - GuruFocus
Discipline and Rules-Based Execution in PRAX Response - Stock Traders Daily
A Look At Praxis Precision Medicines (PRAX) Valuation As Late Stage Epilepsy Plans Move Toward FDA Filings - Sahm
Should Praxis Precision Medicines’ (PRAX) New Clinical Strategy Chief Reshape Its Long-Term Epilepsy Investment Story? - Sahm
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $450 - 富途牛牛
Piper Sandler reiterates Overweight rating on Praxis Precision Medicines stock - Investing.com
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):